Heng-Chen Yao

600 total citations
36 papers, 334 citations indexed

About

Heng-Chen Yao is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Heng-Chen Yao has authored 36 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Heng-Chen Yao's work include Acute Myocardial Infarction Research (9 papers), Advanced Glycation End Products research (5 papers) and Cardiac Ischemia and Reperfusion (4 papers). Heng-Chen Yao is often cited by papers focused on Acute Myocardial Infarction Research (9 papers), Advanced Glycation End Products research (5 papers) and Cardiac Ischemia and Reperfusion (4 papers). Heng-Chen Yao collaborates with scholars based in China, Australia and United States. Heng-Chen Yao's co-authors include Tai Li, Wei Wang, Dong Ren, Shengjun Ma, Mei Zhang, Lexin Wang, Ying Sun, Lei Wu, Lei Gao and Aiping Zhao and has published in prestigious journals such as Scientific Reports, Neuroscience and Medicine.

In The Last Decade

Heng-Chen Yao

34 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng-Chen Yao China 12 123 93 57 51 50 36 334
Huili Lin China 13 116 0.9× 151 1.6× 73 1.3× 51 1.0× 50 1.0× 23 423
Shunsuke Netsu Japan 11 222 1.8× 125 1.3× 49 0.9× 32 0.6× 38 0.8× 19 413
José Alberto Navarro‐García Spain 14 165 1.3× 168 1.8× 69 1.2× 33 0.6× 23 0.5× 39 528
Brittany Balint Canada 10 110 0.9× 107 1.2× 63 1.1× 35 0.7× 21 0.4× 19 372
Brooke Henderson United States 8 123 1.0× 137 1.5× 45 0.8× 22 0.4× 65 1.3× 11 361
Xiao Xiang Yan China 12 117 1.0× 129 1.4× 65 1.1× 73 1.4× 51 1.0× 16 463
Junteng Zhou China 12 84 0.7× 268 2.9× 51 0.9× 50 1.0× 57 1.1× 24 471
Yuyan Shen China 6 132 1.1× 153 1.6× 51 0.9× 19 0.4× 20 0.4× 10 347
Birgit Hausknecht Germany 8 55 0.4× 132 1.4× 44 0.8× 18 0.4× 27 0.5× 10 390
Jianglei Chen United States 10 57 0.5× 157 1.7× 25 0.4× 28 0.5× 45 0.9× 15 359

Countries citing papers authored by Heng-Chen Yao

Since Specialization
Citations

This map shows the geographic impact of Heng-Chen Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng-Chen Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng-Chen Yao more than expected).

Fields of papers citing papers by Heng-Chen Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng-Chen Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng-Chen Yao. The network helps show where Heng-Chen Yao may publish in the future.

Co-authorship network of co-authors of Heng-Chen Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Heng-Chen Yao. A scholar is included among the top collaborators of Heng-Chen Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng-Chen Yao. Heng-Chen Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Min, et al.. (2025). Hemoglobin glycation index can be used as a predictor of diabetes mellitus and prediabetes: a cohort study. BMC Endocrine Disorders. 25(1). 249–249.
2.
Gao, Lei, et al.. (2025). HACE1 protects against myocardial ischemia–reperfusion injury via inhibition of mitochondrial fission in mice. BMC Cardiovascular Disorders. 25(1). 77–77. 2 indexed citations
4.
Wang, Wei, et al.. (2023). The effects of IGF-1 and IGFBP-2 treatments on the atherosclerosis in the aorta and the coronary arteries of the high cholesterol diet-fed rabbits. International Immunopharmacology. 127. 111409–111409. 3 indexed citations
6.
Wang, Wei, et al.. (2023). Circulating IGF-1 and IGFBP-2 may be biomarkers for risk stratification in patients with acute coronary syndrome: A prospective cohort study. Nutrition Metabolism and Cardiovascular Diseases. 33(9). 1740–1747. 2 indexed citations
7.
Yao, Heng-Chen, et al.. (2021). Pratique de l’automesure tensionnelle dans une population d’hypertendus en Afrique subsharienne. Annales de Cardiologie et d Angéiologie. 71(1). 1–5.
8.
Sun, Ying, Wei Wang, Lei Gao, et al.. (2020). Leukocyte Telomere Length: A Potential Biomarker for the Prognosis of Coronary Artery Disease. Biomarkers in Medicine. 14(11). 933–941. 2 indexed citations
9.
Zhou, Yanhong, Lei Gao, Ying Sun, et al.. (2020). HMGB1 Protects the Heart Against Ischemia–Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression. Frontiers in Physiology. 10. 1595–1595. 23 indexed citations
10.
Wang, Wei, et al.. (2019). High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome. Scientific Reports. 9(1). 11583–11583. 23 indexed citations
12.
13.
Zhou, Yanhong, Lanhua Wang, Tao Liu, et al.. (2017). High mobility group box 1 protein attenuates myocardial ischemia reperfusion injury via inhibition of the p38 mitogen-activated protein kinase signaling pathway. Experimental and Therapeutic Medicine. 14(2). 1582–1588. 21 indexed citations
14.
Zhang, Chuanchen, et al.. (2016). Pulmonary Artery Dissection: A Fatal Complication of Pulmonary Hypertension. Case Reports in Medicine. 2016. 1–5. 7 indexed citations
15.
Yao, Heng-Chen, Xiaoyun Li, Lanhua Wang, et al.. (2015). Elevated serum soluble ST2 levels may predict the fatal outcomes in patients with chronic heart failure. International Journal of Cardiology. 186. 303–304. 8 indexed citations
16.
Yao, Heng-Chen, Min Zhou, Yanhong Zhou, et al.. (2015). Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia. Molecular Medicine Reports. 13(2). 1211–1219. 10 indexed citations
17.
Yao, Heng-Chen, et al.. (2013). Inhibitory effect of atorvastatin on the cell growth of cardiac myxomas via the PTEN and PHLPP2 phosphatase signaling pathway. Oncology Reports. 30(2). 757–762. 6 indexed citations
19.
Yao, Heng-Chen, et al.. (2012). Prognostic Values of Serum Tenascin-C in Patients with Ischaemic Heart Disease and Heart Failure. Heart Lung and Circulation. 22(3). 184–187. 12 indexed citations
20.
Yao, Heng-Chen, Takashi Miyamoto, Mitsuhiro Yamamura, et al.. (2003). Long-term results of mitral valve replacement: biological xenograft versus mechanical valves. Journal of Artificial Organs. 6(1). 30–36. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026